Google
Apple
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
BAYER AG |
Real-time Estimate
Other stock markets
|
|
5-day change | 1st Jan Change | |
| 31.88 EUR | -1.57% | +1.67% | -34.02% | |
| 02:00pm | BASF to run agriculture, battery chemicals as separate businesses | RE |
| 10:28am | Bayer: new partnership in ageing well | CF |
| Sales 2023 * | 47.65B 51.4B 4,088B | Sales 2024 * | 48.51B 52.33B 4,162B | Capitalization | 31.82B 34.32B 2,730B |
|---|---|---|---|---|---|
| Net income 2023 * | -860M -928M -73.78B | Net income 2024 * | 3.67B 3.96B 315B | EV / Sales 2023 * | 1,43x |
| Net Debt 2023 * | 36.43B 39.3B 3,126B | Net Debt 2024 * | 34.33B 37.03B 2,945B | EV / Sales 2024 * | 1,36x |
| P/E ratio 2023 * | -11,8x | P/E ratio 2024 * | 9,36x | Employees | 100,873 |
| Yield 2023 * | 6,83% | Yield 2024 * | 6,72% | Free-Float | 99.97% |
More Fundamentals
* Assessed data
More news
More press releases
More news
| 1 day | -1.56% | ||
| 1 week | +1.67% | ||
| Current month | +1.67% | ||
| 1 month | -23.66% | ||
| 3 months | -36.53% | ||
| 6 months | -38.84% | ||
| Current year | -34.02% |
1 week
30.45
32.57
1 month
30.2242.58
Current year
30.2265.66
1 year
30.2265.66
3 years
30.2267.99
5 years
30.2278.34
10 years
30.22146.45
| Managers | Title | Age | Since |
|---|---|---|---|
Wolfgang Nickl
DFI | Director of Finance/CFO | 54 | 2018 |
Bijoy Sagar
CTO | Chief Tech/Sci/R&D Officer | 54 | 2020 |
Itziar Canamasas
PRN | Corporate Officer/Principal | 49 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Colleen Goggins
BRD | Director/Board Member | 68 | 2017 |
| Director/Board Member | 67 | 2017 | |
Alberto Weisser
BRD | Director/Board Member | 67 | 2021 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 9.77% | 70 M€ | -.--% | - | |
| 9.77% | 54 M€ | -.--% | - | |
| 9.71% | 489 M€ | -.--% | ||
| 9.46% | 10 M€ | -15.17% | ||
| 6.69% | 861 M€ | -13.79% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/12/23 | 31.9 | -1.51% | 2 487 793 |
| 06/12/23 | 32.39 | +2.16% | 5,146,308 |
| 05/12/23 | 31.7 | +2.85% | 4,058,062 |
| 04/12/23 | 30.82 | -0.92% | 3,805,359 |
| 01/12/23 | 31.11 | -0.80% | 4,898,592 |
Delayed Quote Xetra, December 07, 2023 at 04:21 pm
More quotes
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows:
- agrochemicals (49.6%): herbicides, fungicides, insecticides, etc.;
- pharmaceutical products (37.9%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.;
- OTC products and nutritional supplements (12%);
- other (0.5%).
Net sales are distributed geographically as follows: Germany (4.9%), Switzerland (1.2%), Europe/Middle East/Africa (22.4%), the United States (30.9%), North America (3.7%), China (8.4%), Asia/Pacific (10.2%), Brazil (10.5%) and Latin America (7.8%).
Sector
Pharmaceuticals
Calendar
05/03/2024
- Q4 2023 Earnings Release
Trading Rating :
Investor Rating :
ESG Refinitiv :
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
32.39EUR
Average target price
50.29EUR
Spread / Average Target
+55.25%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -34.02% | 34 345 M $ | |
| +59.49% | 530 B $ | |
| +42.05% | 438 B $ | |
| -11.81% | 377 B $ | |
| -5.91% | 268 B $ | |
| -8.90% | 258 B $ | |
| -14.04% | 230 B $ | |
| +0.85% | 200 B $ | |
| -9.89% | 198 B $ | |
| -43.86% | 163 B $ |
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition